Identifying reliable biomarkers for the diagnosis and prognosis of Parkinson's disease and atypical parkinsonism could impact both clinical trials and clinical practice. Dr. Antonio Strafella discussed use of molecular imaging biomarkers in research and in the clinic, the process of developing new biomarkers, promising biomarkers that are in development, and more in our latest podcast episode! https://www.michaeljfox.org/podcast/episode-19-current-and-emerging-imaging-biomarkers-diagnosis-and-prognosis-pd-and-atypical

#parkinsons #PD #ParkinsonsDisease #research #science #biomarkers #neuroimaging #podcast #podcasts #scicomm